Michael Lee Milligan

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.69	41,250	69.71 k	41,250
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.69	28,675	48.46 k	28,675
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.69	38,234	64.62 k	38,234
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.69	85,391	144.31 k	85,391
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Sale back to company	Dispose D	No	No	18.07	41,250	745.39 k	0
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Sale back to company	Dispose D	No	No	6.36	28,675	182.37 k	0
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Sale back to company	Dispose D	No	No	6.51	38,234	248.90 k	0
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Sale back to company	Dispose D	No	No	4.63	85,391	395.36 k	0
13 Feb 25	NMRA Neumora Therapeutics, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	1.69	400,000	676.00 k	400,000
14 Feb 24	NMRA Neumora Therapeutics, Inc. Common Stock	Common Stock	Grant	Acquire A	No	No	0	20,625	0.00	24,448

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.